| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5826842 | European Journal of Pharmacology | 2015 | 28 Pages |
Abstract
From literature we conclude that galectin-3 is an active player in cardiac remodeling after myocardial infarction. Future studies should focus on the dynamics of galectin-3 activation after myocardial infarction, and study the possibilities to target galectin-3.
Keywords
LVEFMCPpPCICMRACESTEMICRDIHDNSTEMIN-acetyllactosamineangiotensin converting enzymeMyocardial infarctionCardiac magnetic resonancenon-ST segment elevation myocardial infarctionST-segment elevation myocardial infarctionRemodelingcoronary artery diseaseischemic heart diseaseBiomarkercarbohydrate recognition domainCADFibrosisPrimary percutaneous coronary interventionheart failureModified citrus pectinleft ventricular ejection fractionGalectin-3
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Wouter C. Meijers, A. Rogier van der Velde, Domingo A. Pascual-Figal, Rudolf A. de Boer,